10 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Ilex Medical Ltd. (ILX) operates in the Consumer Discretionary industry and is headquartered in פ"ת, Israel with about 181 employees. Its market capitalization is roughly ₪539 million. In the fiscal year ended 2025-12-31, ILX reported ₪931M in revenue and ₪56M in net income.
Ilex Medical Ltd engages in the import, marketing, distribution and sale of medical laboratory equipment and various diagnostic products, diagnostic systems, and kits and consumables in Israel, the United States, and internationally.
Interactive charts & full statements → Open the ILX valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ₪931M | ₪920M | ₪931M | ₪873M | — | — | — | — | — | — |
| Gross Profit | ₪212M | ₪216M | ₪232M | ₪285M | ₪379M | ₪271M | ₪194M | ₪184M | ₪147M | ₪137M |
| Net Income | ₪56M | ₪39M | ₪51M | ₪102M | ₪197M | ₪126M | ₪65M | ₪52M | ₪42M | ₪29M |
ILS; ₪M / ₪B as marked. Newest period first. Source: company filings via the Israel Securities Authority’s Magna disclosure system.
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividends Paid | ₪14M | ₪15M | ₪21M | ₪60M | ₪60M | ₪0M | ₪25M | ₪18M | ₪15M | ₪10M |
ILS; ₪M / ₪B as marked. Newest period first. Source: company filings via the Israel Securities Authority’s Magna disclosure system.
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | ₪993M | ₪994M | ₪1.0B | ₪899M | ₪875M | ₪779M | ₪582M | ₪533M | ₪485M | ₪488M |
| Cash & Cash Equivalents | ₪176M | ₪177M | ₪148M | ₪201M | ₪259M | ₪160M | ₪50M | ₪56M | ₪58M | ₪45M |
| Total Liabilities | ₪308M | ₪348M | ₪393M | ₪286M | ₪299M | ₪336M | ₪258M | ₪240M | ₪219M | ₪243M |
ILS; ₪M / ₪B as marked. Newest period first. Source: company filings via the Israel Securities Authority’s Magna disclosure system.
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ILX viewer.
This page in other languages: עברית
About TickerBase · Data methodology & sources · Privacy · Terms